| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
AN2 Therapeutics, Inc.
13G/A
ANTX · 037326105
|
7.9% |
2/28/2025
Event 12/31/2024
|
||||
| Adjuvant Global Health Technology Fund, L.P. | 6.7% | |||||
| Adjuvant Global Health Technology Fund DE, L.P. | 1.3% | |||||
| Adjuvant Capital GP, L.P. | 7.9% | |||||
| Adjuvant Capital Management, L.L.C. | 7.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.